Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

PURPOSE: Letrozole showed efficacy and generally favorable toxicities, along with the convenience of oral administration in postmenopausal patients with hormone receptor (HR)–positive metastatic breast cancer (MBC). To the best of our knowledge, there have been no reports of the clinical outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beom, Seung Hoon, Oh, Jisu, Kim, Tae-Yong, Lee, Kyung-Hun, Yang, Yaewon, Suh, Koung Jin, Moon, Hyeong-Gon, Han, Sae-Won, Oh, Do-Youn, Han, Wonshik, Kim, Tae-You, Noh, Dong-Young, Im, Seock-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398408/
https://www.ncbi.nlm.nih.gov/pubmed/27554482
http://dx.doi.org/10.4143/crt.2016.259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398408/
https://www.ncbi.nlm.nih.gov/pubmed/27554482
http://dx.doi.org/10.4143/crt.2016.259

Ejemplares similares